Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03063203. IPD Sharing: NO. Countries: 1. Publications: 0.
Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06668558. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission
ClinicalTrials.gov study NCT02126553. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02953561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04231851. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission
ClinicalTrials.gov study NCT02270463. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
ClinicalTrials.gov study NCT04195945. IPD Sharing: NO. Countries: 1. Publications: 0.
S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01338974. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03315039. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Laboratory-Treated (Central Memory/Naive) CD8+ T Cells in Treating Patients With Newly Diagnosed or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02770820. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant
ClinicalTrials.gov study NCT03537599. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Quizartinib in Combination With Standard Therapies in Chinese Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03723681. IPD Sharing: YES. Countries: 1. Publications: 0.
Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01807091. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lirilumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02399917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04209725. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00037596. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01892371. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02807272. IPD Sharing: NO. Countries: 1. Publications: 0.
BLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With
ClinicalTrials.gov study NCT04284787. IPD Sharing: YES. Countries: 1. Publications: 0.
A Clinical Trial of Cytotoxic T Cells Augmenting Autologous Hematopoietic Stem Cell (AHSC) Transplantation for Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00808080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.